Boston Properties flags $35M impairment on DC Sumner Square sale

Impairment details

On May 27, 2026 BXP’s primary operating subsidiary, Boston Properties Limited Partnership (BPLP), signed a definitive agreement to sell its leasehold interest and building improvements at Sumner Square – comprising 1615 M St, 1625 M St and 1215 17th St – for a gross price of $63 million. The buyer has already placed a non‑refundable cash deposit of $6 million. Because the property’s carrying amount exceeds the expected net proceeds, GAAP impairment testing requires BXP and BPLP to recognize a $18 million and $17 million loss, respectively, in the second quarter of 2026.

Financial impact

The impairment is purely non‑cash, leaving Funds from Operations untouched, but it will reduce net income attributable to each entity by about $0.10 per diluted share for the quarter and the full year. Analysts note that while the hit to earnings is modest, it underscores the company’s ongoing strategic asset‑sale plan unveiled at the September 2025 Investor Day, aimed at redeploying capital into higher‑return projects.

Market reaction

Boston Properties’ shares slipped about 1 % in early trading, settling near $60, as investors priced in the earnings drag and the uncertainty that the sale may not close on the contemplated terms.

Outlook

The filing makes clear that the impairment does not affect cash flow, but it does signal that the firm is actively pruning assets that no longer meet its return thresholds. The transaction’s completion remains subject to customary closing conditions, and the company will monitor the outcome as part of its broader portfolio optimization.

---

Key takeaways - BXP and BPLP will record a total $35 million non‑cash impairment on the Sumner Square property. - The charge reflects a carrying value higher than the $63 million expected net proceeds from the sale. - Earnings per diluted share are projected to decline by ~$0.10 for Q2 and FY 2026. - The impairment has no impact on Funds from Operations but contributes to a modest share‑price dip. - The move aligns with the strategic asset‑sale plan announced at the 2025 Investor Day.